Objectives: Previous studies have shown that mixed-strain gonococcal infections can occur. However, it remains unclear whether such infections impact upon the reliability of Neisseria gonorrhoeae antimicrobial resistance (AMR) surveillance. In this study, we aimed to resolve this question by intensively sampling isolates from gonorrhoea-positive specimens in a high-risk population in Sydney, Australia.
Introduction
Neisseria gonorrhoeae has a remarkable ability to develop resistance to antimicrobial agents. Currently, ceftriaxone is the most effective treatment for gonorrhoea despite the steady rise in gonococcal MICs of extended-spectrum cephalosporins worldwide. There have also been sporadic reports of ceftriaxoneresistant N. gonorrhoeae strains from different parts of the world, raising concerns that gonorrhoea may become untreatable in the foreseeable future. 1 -4 The capacity of the gonococcus to acquire and retain resistance-conferring mutations is attributed to its genetic versatility, including its ability to readily exchange genetic material both between different gonococcal strains and with other Neisseria species through transformation. 5 The presence of multiple gonococcal strains of distinct genetic make-ups in a single anatomical site may be a factor contributing to the emergence of resistant strains. 6 Although several attempts have been made to ascertain the prevalence of mixed-strain gonococcal infections, their true prevalence remains unknown. Previous investigations have provided variable results dependent on the population. 6 -10 For example, a study by Lynn et al. 8 using porB gene sequencing showed that mixed-strain infections accounted for up to 40% of total infections among commercial sex workers in Baltimore, USA. A more recent study by our group using porB gene PCR methods estimated a prevalence rate of only 1.3% in a subset of the general population presenting for sexual health screening. 10 Whilst it is evident that mixed-strain gonococcal infections do occur, there is limited evidence to show that such mixtures have involved strains of different antimicrobial susceptibility. 11 Moreover, it remains unclear whether the true prevalence of resistant strains within a population can potentially be underestimated due to 
Methods

Overview
Seven-hundred suspected N. gonorrhoeae isolates, originating from 32 rectal swabs and 38 throat swabs (10 isolates from each specimen; 61 males and nine females) were initially included in the study. Specimens from these high-risk anatomical sites were chosen for this study, as mixed infections are more likely to be present in these sites. All isolates were subject to N. gonorrhoeae identification, antimicrobial susceptibility testing and genotyping by SNP-based MLST.
Patient specimens
The study was conducted over the period March to June 2015, in Sydney, Australia using primary isolation plates. The study targeted patients attending sexual health clinics in inner Sydney during a period known for high tourism activity in Sydney. These populations and time frame were selected to maximize our chances of detecting mixed-strain infections. All specimens were de-identified for the study.
Ethics
Ethics approval for the study was provided by the Human Research Ethics Committee, Prince of Wales Hospital Sydney (reference number 15/011). A waiver of patient consent was approved by the above ethics committee.
Culture identification and isolate selection
Patient specimens were inoculated on to chocolate agar plates at the clinics and transported to the laboratory in transfer jars supplemented with 5% CO 2 . The plates were then incubated under standard conditions for 18-24 h as per Australian Gonococcal Surveillance Programme protocols. 12 Following 18-24 h of incubation, chocolate agar plates exhibiting growth of colonies resembling N. gonorrhoeae were screened using oxidase and superoxol tests. Diagnostic testing and reporting were performed on all patient specimens as per the routine protocol at the Microbiology Department, Prince of Wales Hospital. Following this, plates inoculated with patient specimens and positive for N. gonorrhoeae were included into the study. Isolate selection from each plate was performed using a standard protocol developed to ensure maximal representation of distribution of colonies on the primary plates. Briefly, chocolate agar plates were divided into four equal sectors designated zones 1 -4, ensuring that the primary inoculum was confined within zone 1. A total of 10 isolated colonies, two from zone 2 and four isolated colonies each from zone 3 and zone 4 were sub-cultured on to lysed blood agar plates and incubated under standard conditions. 12 Where the bacterial growth did not extend to the final streaks, the sectors were determined by equal division of area between margin of primary inoculum and final isolated colonies. Growth from each of 10 lysed blood agar plates per patient specimen were inspected at 24 h. Isolates were identified via MALDI-TOF MS (Bruker Daltonics, Bremen, Germany) according to the manufacturer's instructions.
Antimicrobial susceptibility testing and MLST
Susceptibility to ceftriaxone, penicillin and azithromycin was determined via the Etest method. 13 MIC values were determined and cross-checked by two independent operators and any discrepancy (defined by .2 log difference in MIC values) was investigated by repeat testing. Isolates were also genotyped using a previously described SNP-based MLST method.
14 Briefly, nucleic acids were extracted from the isolates using a heatdenaturation method and assayed by Sequenom iPLEX MassARRAY.
Results
Of the initial 70 specimens (700 isolates) that underwent strain isolations, seven specimens (one rectal and six throat swabs; 85 isolates) were excluded from the study because the majority of isolates (five or more from each sample) were not confirmed as N. gonorrhoeae. A total of 615 N. gonorrhoeae isolates were obtained from the remaining 63 specimens, comprising 31 rectal (R01-R31) and 32 throat swab (T01 -T32) specimens; SNP-based MLST and AMR susceptibility profiles for all 615 isolates are provided in Table S1 (available as Supplementary data at JAC Online). A total of 18 different MLST types were observed for the 63 specimens (Table S1 ). With the exception of two rectal swabs (R18 and R27; Table S1), the SNP-based MLST results were identical for all isolates from the same sample. For samples R18 and R27, two different SNP-MLST types were identified in each sample. In both cases, there were eight isolates of one MLST type and two isolates of the other type. For sample R18 the observed MLST types differed by four SNPs across three genes (abcZ, fumC and aroE). For R27 the MLST types differed by two SNPs across two genes (abcZ and fumC). The AMR susceptibility profiles for the different genotypes from both samples were indistinguishable.
Within-sample categorical differences in the AMR susceptibility profiles were observed for a further 13 samples (eight rectal and five throat swabs; Table S1 ); five samples (R05, R21, R24, T08 and T11) comprised mixtures of isolates exhibiting susceptibility and decreased susceptibility to ceftriaxone, six samples (T05, T07, R08, R17, R24 and R25) comprised a mixture of isolates exhibiting susceptibility and resistance to azithromycin, and three samples (R07, R30 and T19) comprised mixtures of isolates exhibiting susceptibility and resistance to penicillin. However, for all 13 samples where categorical differences were observed, the MIC values were typically within a 2-fold difference of each other and were close to the breakpoint of each respective AMR category.
Discussion
In this study, we used intensive isolate sampling coupled with genotyping and AMR susceptibility testing to explore the prevalence of mixed-strain gonococcal infections in our local population. A key goal was to determine whether mixed infections have the potential to impinge upon the reliability of N. gonorrhoeae AMR surveillance in our country. Overall, our data suggest that mixed-strain infections have little impact upon N. gonorrhoeae AMR surveillance.
In total, we identified only two of 63 (3.2%) samples that could definitively be considered as representing mixed-strain infections (rectal swabs R18 and R27; Table S1 ). Notably, these two mixedstrain infections were identified based on the genotyping data and not the susceptibility profiles, which were indistinguishable for both genotypes from both samples. The genotypes from both cases differed by at least two SNPs across two genes and Goire et al.
therefore were unlikely to be variants of the same isolate, but rather were different infecting strains. Whilst some categorical differences in susceptibility profiles were observed for a further seven samples, we do not consider these significant. This is because the observed differences were typically within the expected measurement of uncertainty of the Etest method (plus or minus one 2-fold dilution) or and were close to the AMR category breakpoint.
It should also be noted that the populations we targeted were selected to maximize our chances of detecting mixed-strain infections; focusing on high-risk populations during a period known for increased visitor numbers and tourism-related activities in Sydney. We would therefore expect ,3.2% infections to be mixedstrain infections if testing a broader population and is consistent with our previous estimate of 1.3% for a general screening population, 10 which was achieved using purely molecular (non-culture) techniques.
One potential limitation of our study was that an SNP-based MLST approach was employed for genotyping. MLST methods lack the discrimination of other genotyping methods, such as NG-MAST, and so it may be possible that our methods have underestimated the number of mixed-strain type infections. Nevertheless, we do not see this as a major limitation impacting upon the study given the MLST protocol targets core genomic regions, rather than variable genes that readily mutate, and therefore provides a more valid means of distinguishing gonococcal strains.
In conclusion, the results of this study provide further evidence that mixed-strain gonococcal infections do occur, although at low prevalence. Our data also indicate that such infections are unlikely to impact significantly upon N. gonorrhoeae AMR surveillance at a population level.
